Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

Monday’s trading has closed, but ALT is being traded in the after-hours session. After-Hours quote »
2.72
Delayed Data
As of 3:59pm ET
 +0.06 / +2.26%
Today’s Change
2.01
Today|||52-Week Range
14.70
-29.18%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close2.66
Today’s open2.70
Day’s range2.65 - 2.84
Volume198,356
Average volume (3 months)92,185
Market cap$41.5M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.93

Competitors

 Today’s
change
Today’s
% change
--Molecular Templates ...-0.29-3.19%
NVIVInVivo Therapeutics ...-0.05-3.33%
HSGXHistogenics Corp0.000.00%
AZRXAzurRx BioPharma Inc-0.21-5.98%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts